講演・口頭発表等 - 横田 隆徳

分割表示  735 件中 141 - 160 件目  /  全件表示 >>
  1. Taiki Kunieda, Kotaro Yoshioka, Yumiko Sujino, Kie Tanaka, Wenying Piao, Hiroya Kuwahara, Kazutaka Nishina, Tetsuya Nagata, Takanori Yokota. Pharmacokinetic study of double stranded antisense oligonucleotide: Hetero Chimera Duplex Oligonucleotide (HCDO). 12th Annual Meeting of the Oligonucleotide Therapeutics Society 2016.09.26 Montreal

  2. Takanori Yokota. Propagation of TDP-43 in ALS. Propagation in Neurodegenerative Disease Conference 2016 2016.08.11 Dublin

  3. Yoichiro Nishida, Daishi Yui, Tomoko Nishina, Kaoru Mogushi, Satoru Ishibashi, Itsuki Ajioka, Kinya Ishikawa, Hidehiro Mizusawa, Shigeo Murayama, Takanori Yokota. Enhanced Pla2g3 expression by oxidative stress decreases the IDE and exacerbates AD. Alzheimer's Association International Conference 2016 2016.07.26 Toronto

  4. Fumiko Furukawa, Nobuo Sanjo, Atsushi Kobayashi, Tsuyoshi Hamaguchi, Masahito Yamada, Tetsuyuki Kitamoto, Hidehiro Mizusawa, Takanori Yokota. Colocalization of Aβ42 with PrPSc-plaques in the brain of the Gerstmann-Sträussler-Scheinker disease with the P105L mutation. Alzheimer's Association International Conference 2016 2016.07.24 Toronto

  5. Kazutaka Nishina, Kie Yoshida-Tanaka, Wenying Piao, Takanori Yokota. DNA/RNA heteroduplex oligonucleotide (HDO) for highly efficient gene silencing. The RNA society of Japan 18th annual meeting (The 21st annual meeting of the RNA society) 2016.06.30 Kyoto

  6. Taiki Kunieda, Kotaro Yoshioka, Yumiko Sujino, Kie Tanaka, Wenying Piao, Hiroya Kuwahara, Kazutaka Nishina, Tetsuya Nagata, Takanori Yokota. Development of antisense oligonucleotide with a new type of a double stranded structure. The RNA society of Japan 18th annual meeting (The 21st annual meeting of the RNA society) 2016.06.29 Kyoto

  7. Fumika Sakaue, Eiji Yasuda, Tatsuhiko Sano, Taro Ishiguro, Tetsuya Nagata, Takanori Yokota. Chemically modified RNAs inhibit TDP-43 aggregation. The RNA society of Japan 18th annual meeting (The 21st annual meeting of the RNA society) 2016.06.29 Kyoto

  8. Kotaro Yoshioka, Yumiko Sujino, Taiki Kunieda, Kie Tanaka, Wenying Piao, Hiroya Kuwahara, Kazutaka Nishina, Tetsuya Nagata, Takanori Yokota. A new mechanism of microRNA inhibition by a new type of duplex oligonucleotide. The RNA society of Japan 18th annual meeting (The 21st annual meeting of the RNA society) 2016.06.29 Kyoto

  9. Hiroshi Doi, Shigeru Koyano, Misako Kunii, Shunta Hashiguchi, Hitaru Kishida, Kenichi Tanaka, Masaaki Shiina, Kazuhiro Ogata, Fumiko Hirashima, Yukichi Inoue, Nozomu Sato, Kokoro Ozaki, Kiyobumi Ohta, Takanori Yokota, Hidehiro Mizusawa, Jun Mitsui, Shoji Tsuji, Naomichi Matsumoto, Kinya Ishikawa, Fumiaki Tanaka. The clinical and pathological features of autosomal-dominant SCA with CACNA1G mutation. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.21 Kobe

  10. Keisuke Abe, Mio Tajiri, Daishi Yui, Hiroki Sasaguri, Takuya Ohkubo, Takanori Yokota. A C-terminal fragment of TDP-43 in exosomes mediates propagation of ALS pathology. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.20 Kobe

  11. Masahiko Ichijo, Satoru Ishibashi, Kazunori Miki, Eri Iwasawa, Kyohei Fujita, Hiroaki Yokote, Takeshi Amino, Tomoyuki Kamata, Takanori Yokota. Significance of development and reversion of collaterals in outcome after intravenous thrombolysis. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.20 Kobe

  12. Toshiro Kanazawa, Yurie Nose, Yutaro Asami, Jin Nonami, Masahide Iijima, Hiroaki Tanaka, Takanori Yokota. Clinical features of patients with motor fluctuations before intravenous thrombolysis. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.20 Kobe

  13. Kazumasa Soga, Kinya Ishikawa, Tokuro Huruya, Hidehiro Mizusawa, Takanori Yokota. A clinical and neuropathological study on homozygous mutations with spinocerebellar ataxia type 6. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.20 Kobe

  14. Yoichiro Nishida, Winkler Ethan, Sagare Abhay, De Vivo Darryl, Zlokovic Berislav. GLUT1 reductions at the BBB exacerbate Alzheimer disease vasculo-neuronal dysfunction. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.19 Kobe

  15. Ogata H, Yamasaki R, Oka N, Kuwahara M, Suzuki H, Kusunoki S, Yagi Y, Yokota T, Matsushita T, Kira J-I. Useful laboratory markers for predicting anti-NF155 antibody status among CIDP patients. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.19 Kobe

  16. Kazutaka Nishina, Kotaro Yoshioka, Tomoko Nishina, Hiroya Kuwahara, Tetsuya Nagata, Takanori Yokota. Novel oligonucleotide based on DNA/RNA heteroduplex structures. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.19 Kobe

  17. Kotaro Yoshioka, Taiki Kunieda, Kie Tanaka, Wenying Piao, Hiroya Kuwahara, Kazutaka Nishina, Tetsuya Nagata, Takanori Yokota. A new type of double–stranded structure improved potency of antisense oligonucleotide for FAP. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.19 Kobe

  18. Eri Iwasawa, Satoru Ishibashi, Masahiko Ichijo, Fu Ying Li, Takanori Yokota. Upregulation and distribution of sphingosine-1-phosphate receptor 1 in acute ischemic stroke. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.19 Kobe

  19. Nozomu Sato, Kinya Ishikawa, Hidehiro Mizusawa, Takanori Yokota. Variations in the mutation for spinocerebellar ataxia type 31 require cautious genetic testing. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.19 Kobe

  20. Jindong Song, Tetsuya Nagata, Wenying Piao, Kazutaka Nishina, Takuya Okubo, Keisuke Abe, Masato Hasegawa, Takanori Yokota. Inhibition of alpha-synuclein fibril assembly by antisense oligonucleotide in mice. 57th Annual Meeting of the Japanese Society of Neurology 2016.05.18 Kobe

このページの先頭へ▲